My laboratory uses a combination of biological approaches including genomic, computational/bioinformatic, evolutionary, molecular, cellular and developmental methods for an integrated approach to prostate cancer research concentrated on identifying the underlying cause of observed disparities in prostate cancer incidence rates between men with different genetic ancestries now living in the United States in order to develop effective strategies for prevention and treatment of prostate cancer in all men.